Net Income Common - Oncolys Biopharma Inc (TSE:4588) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 706 JPY -0.56%

Updated:

Oncolys Biopharma Inc
Net Income (Common)

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Oncolys Biopharma Inc
Net Income (Common) Peer Comparison

2160

4587

4974

J

7774

S

4599

Company		Net Income (Common)	CAGR 3Y	CAGR 5Y	CAGR 10Y
O	Oncolys Biopharma Inc TSE:4588	Net Income (Common) -¥1.9B	CAGR 3-Years 3%	CAGR 5-Years -9%	CAGR 10-Years N/A
	GNI Group Ltd TSE:2160	Net Income (Common) ¥8.1B	CAGR 3-Years 86%	CAGR 5-Years N/A	CAGR 10-Years N/A
	PeptiDream Inc TSE:4587	Net Income (Common) ¥3B	CAGR 3-Years -12%	CAGR 5-Years -3%	CAGR 10-Years N/A
	Takara Bio Inc TSE:4974	Net Income (Common) ¥1.6B	CAGR 3-Years -39%	CAGR 5-Years -14%	CAGR 10-Years 2%
J	Japan Tissue Engineering Co Ltd TSE:7774	Net Income (Common) -¥157.2m	CAGR 3-Years 22%	CAGR 5-Years 15%	CAGR 10-Years 17%
S	StemRIM Inc TSE:4599	Net Income (Common) ¥168.4m	CAGR 3-Years -21%	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Oncolys Biopharma Inc's Net Income (Common) amounts to -1.9B JPY.

Over the last year, the Net Income (Common) growth was -69%. The average annual Net Income (Common) growth rates for Oncolys Biopharma Inc have been 3% over the past three years , -9% over the past five years .

Join more than 133,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.